Speed to IND for Biologics

October 17 - 18, 2018 - San Fransisco MA US

CBI

matthew.douglas@cbinet.com
Phone:+1-339-298-2144

This event has been developed specifically for senior-level executives, directors, managers, senior scientists and engineers working in the following areas: R&D, Bioprocessing, Process Development, Process Sciences, Process Engineering, Cell Line Development, Cell Science and Technology, Cell Culture, Upstream Process Development, Harvest, Purification, Downstream Process Development, Analytical Development, Analytical Sciences Formulation, CMC, Technical Development, Manufacturing Science & Technology, Pre-Clinical Manufacturing CBI’s Speed to IND for Biologics provides a comprehensive, cross-functional format that brings together experts from every department to share their perspectives, achievements and lessons learned as a community working towards the common goal of accelerating speed while managing and mitigating risk. Take Part in this Interactive Forum to Discuss and Determine the Best Approaches To: • Accelerate the Transition from R&D to Development • Address Cell Line Development Needs Using New Technologies and Alternate Strategies • Overlap Activities to Compress Timelines • Determine Best Technologies in Analytical and Process Sciences that Enable Compressed Timelines • Accelerate Development of New Modalities and Approaches to IND Filing • Integrate a Cross-Functional Approach to Successfully Manage Critical Path to IND • Determine and Mitigate the Technical, Manufacturing and Regulatory Risks • Address Regulatory and Quality Challenges in Accelerating Timelines

More Information